Curtis Gale Oltmans - 09 Feb 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Legal Officer
Signature
/s/ Curt Oltmans
Issuer symbol
FULC
Transactions as of
09 Feb 2023
Net transactions value
$0
Form type
4
Filing time
13 Feb 2023, 15:15:31 UTC
Previous filing
11 Aug 2022
Next filing
28 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 09 Feb 2023 Common Stock 150,000 $12.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on February 9, 2023 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2023, subject to the reporting person's continued service on each such vesting date.